C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 38/17 (2006.01) A61P 25/22 (2006.01) G01N 33/53 (2006.01)
Patent
CA 2564316
The present invention provides methods for diagnosing or identifying susceptibility of a subject to an anxiety or mood disorder. One method involves testing a sample obtained from the subject for the presence of a polymorphism in Intron 10 of the SLC1A1 gene. The presence of allele G or allele A of the A/G polymorphism rs301434 indicates that the patient is susceptible to an anxiety disorder. An alternate method involves testing a sample obtained from the subject for the presence of a polymorphism in the 3' untranslated region of the SLC1A1 gene. The presence of allele C of C/G polymorphism rs3087879 indicates that the patient is susceptible to an anxiety disorder. Furthermore, a method is provided that involves testing a sample obtained from the subject for the presence of a haplotype in the SLC1A1 gene, wherein the combined presence allele G of the A/G polymorphism rs301434 and allele C of C/G polymorphism rs3087879 indicates that the patient is susceptible to a mood disorder.
Arnold Paul Daniel
Kennedy James Lowery
Richter Margaret A.
Centre For Addiction And Mental Health
Gowling Lafleur Henderson Llp
LandOfFree
Slc1a1 marker for anxiety disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Slc1a1 marker for anxiety disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slc1a1 marker for anxiety disorder will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1602161